Sequencing the head and neck cancer genome: implications for therapy

被引:37
|
作者
Sun, Wenyue [1 ]
Califano, Joseph A. [1 ,2 ]
机构
[1] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21231 USA
[2] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Canc, Baltimore, MD USA
来源
ANNALS REPORTS, VOL 1333 | 2014年 / 1333卷
关键词
head and neck cancer; next-generation sequencing; mutation; NOTCH1; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; ORAL-CAVITY; PHASE-I; MUTATIONAL LANDSCAPE; OROPHARYNGEAL CANCER; PIK3CA MUTATIONS; TP53; MUTATIONS; PI3K PATHWAY; NOTCH;
D O I
10.1111/nyas.12599
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Head and neck squamous cell carcinoma (HNSCC) is a disease with significant morbidity and mortality. The advancement of next-generation sequencing technologies now enables the landscape of genetic alterations in HNSCCs to be deciphered. In this review, we describe the mutation spectrum discovered in HNSCCs, especially human papilloma virus-associated and/or tobacco smoke exposure-associated HNSCCs. We also describe related research from two independent investigators and from the Cancer Genome Atlas. Emphasis is placed on the therapeutic implications of genes frequently altered in HNSCCs (i.e., TP53, PIK3CA, and NOTCH1) and their corresponding pathways, with a particular focus on recent findings of Notch signaling pathway activation in HNSCC. We also discuss the application of integrated genomic pathway-based analysis for precision cancer therapy in HNSCC.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [21] Radiation therapy in head and neck cancer
    Alfouzan, Afnan F.
    SAUDI MEDICAL JOURNAL, 2021, 42 (03) : 247 - 254
  • [22] Targeted therapy in head and neck cancer
    Bianchini, Chiara
    Ciorba, Andrea
    Pelucchi, Stefano
    Piva, Roberta
    Pastore, Antonio
    TUMORI, 2011, 97 (02) : 137 - 141
  • [23] Decision Trees Predicting Tumor Shrinkage for Head and Neck Cancer: Implications for Adaptive Radiotherapy
    Surucu, Murat
    Shah, Karan K.
    Mescioglu, Ibrahim
    Roeske, John C.
    Small, William, Jr.
    Choi, Mehee
    Emami, Bahman
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (01) : 139 - 145
  • [24] The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?
    Burtness, Barbara
    CANCER, 2018, 124 (01) : 14 - 17
  • [25] Defining the genomic landscape of head and neck cancers through next-generation sequencing
    Rizzo, G.
    Black, M.
    Mymryk, J. S.
    Barrett, J. W.
    Nichols, A. C.
    ORAL DISEASES, 2015, 21 (01) : E11 - E24
  • [26] SELECTIVE NECK DISSECTION FOLLOWING ADJUVANT THERAPY FOR ADVANCED HEAD AND NECK CANCER
    Mukhija, Vijay
    Gupta, Sachin
    Jacobson, Adam S.
    Eloy, Jean Anderson
    Genden, Eric M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (02): : 183 - 188
  • [27] Gene Therapy in Head and Neck Cancer
    Farmer, Zachary L.
    Kim, Edward S.
    Carrizosa, Daniel R.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2019, 31 (01) : 117 - +
  • [28] Integrating genomics in head and neck cancer treatment: Promises and pitfalls
    Thariat, Juliette
    Vignot, Stephane
    Lapierre, Ariane
    Falk, Alexander T.
    Guigay, Joel
    Van Obberghen-Schilling, Ellen
    Milano, Gerard
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 95 (03) : 397 - 406
  • [29] Global Burden of Head and Neck Cancer
    Rahman, Quazi Billur
    Iocca, Oreste
    Kufta, Kenneth
    Shanti, Rabie M.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2020, 32 (03) : 367 - +
  • [30] HPV Associated Head and Neck Cancer
    Spence, Tara
    Bruce, Jeff
    Yip, Kenneth W.
    Liu, Fei-Fei
    CANCERS, 2016, 8 (08)